Streetbeat News

STSS

Sharps Technology, Inc.

https://sharpstechnology.com

Industry

Medical - Instruments & Supplies

Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.

Open

1.99

Mkt cap

3.7M

Volume

98K

High

2.15

P/E Ratio

-0.26

52-wk high

18.15

Low

1.95

Div yield

N/A

52-wk low

1.70

Sharps Technology's CEO, Robert Hayes, issued a shareholder letter detailing plans to expand their manufacturing facility in Hungary. This expansion aims to increase the supply and revenue of their SecureGard and SoloGard syringe products.

Portfolio Pulse from

December 05, 2024 | 3:15 pm

Sharps Technology announced a 1-for-22 reverse stock split effective October 15, 2024, to comply with Nasdaq's minimum bid price requirement.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 12:19 pm

The article highlights the intraday movements of several healthcare stocks on Wednesday. Notable gainers include Tenon Medical, Bone Biologics, and CERo Therapeutics, while Sharps Technology, Senti Biosciences, and Windtree Therapeutics were among the losers.

Portfolio Pulse from Benzinga Insights

September 25, 2024 | 2:42 pm

Sharps Technology shares declined following the announcement of a $3.5 million secured bridge loan financing agreement with institutional investors.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 6:51 pm

Sharps Technology has entered into definitive agreements with institutional investors for a secured bridge loan financing of approximately $3.5 million. This move is likely aimed at bolstering the company's financial position.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 10:01 am

Sharps Technology has received approval from Nasdaq to maintain its listing, contingent on completing a reverse stock split to address a bid price deficiency. The company plans to execute the reverse split following an exception from the Nasdaq Hearings Panel.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:04 pm

Sharps Technology, Inc. (NASDAQ: STSS) has entered into a 5-year sales agreement with a U.S. medical products company, generating over $50M in new revenue for its EU facility. The agreement sells out the 10mL SoloGard production capacity and necessitates expansion to meet future demand.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 12:34 pm

U.S. stocks traded mostly higher with the Nasdaq Composite gaining over 150 points. Key movers included Koss Corporation, Macy’s, Sharps Technology, NIO Inc., Eshallgo Inc., and XPeng Inc. Gold and silver prices rose, while oil prices fell.

Portfolio Pulse from Avi Kapoor

July 05, 2024 | 7:35 pm

NIO Inc. (NYSE:NIO) shares fell 8.5% after the resignation of CFO Steven Wei Feng. Other notable movers include Qualigen Therapeutics, Inc. (NASDAQ:QLGN) up 120%, Zapp Electric Vehicles Group Limited (NASDAQ:ZAPP) up 70.5%, and Macy’s, Inc. (NYSE:M) up 10.4% due to an increased acquisition bid. XPeng Inc. (NYSE:XPEV) declined 10% after announcing vehicle delivery figures.

Portfolio Pulse from Avi Kapoor

July 05, 2024 | 4:59 pm

U.S. stocks traded mostly higher with the Nasdaq Composite gaining over 100 points. Key movers included Koss Corporation, Macy’s, Sharps Technology, NIO Inc., Eshallgo Inc., and XPeng Inc. Nonfarm payrolls increased by 206,000, slightly above expectations.

Portfolio Pulse from Avi Kapoor

July 05, 2024 | 4:11 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.